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Abstract 
Short communication on t(9;10)(q34;q22) 
ZMIZ1/ABL1, with data on clinics, and the genes 
implicated. 
Clinics and pathology 
Note 
Only five cases to date have been described with a 
t(9;10)(q34;q22).  
Two cases of acute myeloid leukemia (AML) are 
herein excluded from the study, because they are 
likely to represent another entity, with perhaps 
different genes involved.  
These are two patients aged 44 years (1 female and 
1 male), one with a M1-AML, and the other one 
with a M3-AML and the classical 
t(15;17)(q22;q21), both with a complex karyotype 
and no further data (Sato et al., 1995; Schoch et al., 
1996). 
Disease 
B-cell acute lymphoblastic leukemia (B-ALL). 
Phenotype/cell stem origin 
One case was phenotyped as a CD10+ B-ALL. 
Epidemiology 
Three cases to date, 1 male / 2 female patients, all 
are paediatric cases so far, one was a 1.5 year old 
baby (Cooley et al., 2007; Rabin et al., 2008; Soler 
et al., 2008). 
Prognosis 
Scarce data, no follow-up; one case was noted as 
being in complete remission. 
 
Cytogenetics 
Cytogenetics morphological 
Additional abnormalities were found in the three 
cases (complex karyotype in two cases). A del(13q) 
was found in one case. 
Genes involved and 
proteins 
ABL1 
Location 
9q34.12 
Protein 
1130-1143 amino acids; ABL1 is composed from 
N-term to C-term of a CAP, a SRC homology 3 
(SH3), SH2 and SH1 tyrosine kinase domains, a 
conserved PXXP motifs to mediate protein-protein 
interactions, three nuclear localization signal (NLS) 
motifs, a DNA-binding domain, a globular 
(G).actin-binding domain, one nuclear export signal 
(NES), and a conserved filamentous actin-binding 
domain. Regulates endocytosis, epithelial-
to.mesenchymal transition, cell polarity, adhesion, 
migration and invasion; in response to cellular 
stress, including DNA damage, ABL1 induces 
growth arrest and/or apoptosis (review in Greuber 
et al., 2013). 
Somatic mutations 
Apart from the well known role of ABL1 in 
leukemias, ABL1 has been found overexpressed in 
a small percentage of breast carcinomas, lung 
squamous cell carcinomas, and uterine corpus 
carcinomas. 
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t(9;10)(q34;q22) ZMIZ1/ABL1 protein. 
 
ZMIZ1 
Location 
10q22.3 
Protein 
1067 amino acids (aa). ZMIZ1 is composed from 
N-term to C-term of a proline-rich region (aa 363-
555 (334-555 according to Swiss-Prot)), a nuclear 
localization signal sequence (aa 691-713), a Miz 
domain (aa 738-790 (Zn finger 727-804 according 
to Swiss-Prot)), and a proline-rich region 
(transcriptional activation domain) (aa 824-1067 
((867-1002 according to Swiss-Prot)).  
The central region between aa 556 and 790 is the 
primary binding region for AR (Sharma et al., 
2003). Sequence specific DNA binding protein. 
Transcriptional coactivator related to members of 
the proteatggactin inhibitor of activated STAT 
(PIAS) family.  
Co-activator of AR (androgen receptor).  
Increases ligand-dependent transcriptional activity 
of AR, SMAD3, and TP53. ZMIZ1 is able to 
enhance the sumoylation of AR.  
ZMIZ1 cooperates with NOTCH1 to regulate the 
C-MYC pathway.  
ZMIZ1 is overexpressed in a subset of T-ALL 
(Rakowski et al., 2013). 
Result of the chromosomal 
anomaly 
Hybrid gene 
Note 
A ZMIZ1/ABL1 hybrid gene was searched for and 
detected in one case to date (Soler et al., 2003). 
Description 
5' ZMIZ1-3'ABL1. The exon 14 of ZMIZ1 is fused 
to exon 2 of ABL1. 
Fusion protein 
Description 
197 kDa, 1812 amino acids fusion protein, 
containing the N-term proline-rich domain of 
ZMIZ1 and most of ABL1. 
Oncogenesis 
ZMIZ1/ABL1 may encode a constitutively 
activated tyrosine kinase. 
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